Prediction of permanent pacemaker implantation after transcatheter aortic valve replacement: The role of machine learning.
Machine learning
Permanent pacemaker implantation
Transcatheter aortic valve replacement
Journal
World journal of cardiology
ISSN: 1949-8462
Titre abrégé: World J Cardiol
Pays: United States
ID NLM: 101537090
Informations de publication
Date de publication:
26 Mar 2023
26 Mar 2023
Historique:
received:
25
11
2022
revised:
04
01
2023
accepted:
01
03
2023
medline:
11
4
2023
entrez:
10
4
2023
pubmed:
11
4
2023
Statut:
ppublish
Résumé
Atrioventricular block requiring permanent pacemaker (PPM) implantation is an important complication of transcatheter aortic valve replacement (TAVR). Application of machine learning could potentially be used to predict pre-procedural risk for PPM. To apply machine learning to be used to predict pre-procedural risk for PPM. A retrospective study of 1200 patients who underwent TAVR (January 2014-December 2017) was performed. 964 patients without prior PPM were included for a 30-d analysis and 657 patients without PPM requirement through 30 d were included for a 1-year analysis. After the exclusion of variables with near-zero variance or ≥ 50% missing data, 167 variables were included in the random forest gradient boosting algorithm (GBM) optimized using 5-fold cross-validations repeated 10 times. The receiver operator curve (ROC) for the GBM model and PPM risk score models were calculated to predict the risk of PPM at 30 d and 1 year. Of 964 patients included in the 30-d analysis without prior PPM, 19.6% required PPM post-TAVR. The mean age of patients was 80.9 ± 8.7 years. 42.1 % were female. Of 657 patients included in the 1-year analysis, the mean age of the patients was 80.7 ± 8.2. Of those, 42.6% of patients were female and 26.7% required PPM at 1-year post-TAVR. The area under ROC to predict 30-d and 1-year risk of PPM for the GBM model (0.66 and 0.72) was superior to that of the PPM risk score (0.55 and 0.54) with a The GBM model has good discrimination and calibration in identifying patients at high risk of PPM post-TAVR.
Sections du résumé
BACKGROUND
BACKGROUND
Atrioventricular block requiring permanent pacemaker (PPM) implantation is an important complication of transcatheter aortic valve replacement (TAVR). Application of machine learning could potentially be used to predict pre-procedural risk for PPM.
AIM
OBJECTIVE
To apply machine learning to be used to predict pre-procedural risk for PPM.
METHODS
METHODS
A retrospective study of 1200 patients who underwent TAVR (January 2014-December 2017) was performed. 964 patients without prior PPM were included for a 30-d analysis and 657 patients without PPM requirement through 30 d were included for a 1-year analysis. After the exclusion of variables with near-zero variance or ≥ 50% missing data, 167 variables were included in the random forest gradient boosting algorithm (GBM) optimized using 5-fold cross-validations repeated 10 times. The receiver operator curve (ROC) for the GBM model and PPM risk score models were calculated to predict the risk of PPM at 30 d and 1 year.
RESULTS
RESULTS
Of 964 patients included in the 30-d analysis without prior PPM, 19.6% required PPM post-TAVR. The mean age of patients was 80.9 ± 8.7 years. 42.1 % were female. Of 657 patients included in the 1-year analysis, the mean age of the patients was 80.7 ± 8.2. Of those, 42.6% of patients were female and 26.7% required PPM at 1-year post-TAVR. The area under ROC to predict 30-d and 1-year risk of PPM for the GBM model (0.66 and 0.72) was superior to that of the PPM risk score (0.55 and 0.54) with a
CONCLUSION
CONCLUSIONS
The GBM model has good discrimination and calibration in identifying patients at high risk of PPM post-TAVR.
Identifiants
pubmed: 37033682
doi: 10.4330/wjc.v15.i3.95
pmc: PMC10074998
doi:
Types de publication
Journal Article
Langues
eng
Pagination
95-105Informations de copyright
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Références
N Engl J Med. 2019 May 2;380(18):1695-1705
pubmed: 30883058
J Am Coll Cardiol. 2017 May 30;69(21):2657-2664
pubmed: 28545640
Bone Marrow Transplant. 2014 Mar;49(3):332-7
pubmed: 24096823
Eur Heart J. 2014 Jun 21;35(24):1588-98
pubmed: 24022003
Int J Cardiol. 2014 Jun 1;174(1):1-6
pubmed: 24750717
JACC Cardiovasc Interv. 2019 Nov 11;12(21):2133-2142
pubmed: 31699374
J Am Coll Cardiol. 2013 Sep 10;62(11):1026-34
pubmed: 23644082
Circulation. 2014 Mar 18;129(11):1233-43
pubmed: 24370552
JACC Cardiovasc Interv. 2016 Nov 14;9(21):2189-2199
pubmed: 27832844
J Am Coll Cardiol. 2015 Dec 29;66(25):2813-2823
pubmed: 26652232
J Am Coll Cardiol. 2014 Dec 2;64(21):2235-43
pubmed: 25456759
JACC Cardiovasc Interv. 2015 Jan;8(1 Pt A):60-9
pubmed: 25616819
JACC Cardiovasc Interv. 2010 May;3(5):524-30
pubmed: 20488409
Circulation. 2012 Aug 7;126(6):720-8
pubmed: 22791865
Nat Rev Cardiol. 2011 Nov 15;9(1):15-29
pubmed: 22083020
Heart. 2018 Jul;104(14):1156-1164
pubmed: 29352006
Europace. 2012 Dec;14(12):1759-63
pubmed: 22733983
N Engl J Med. 2010 Oct 21;363(17):1597-607
pubmed: 20961243
N Engl J Med. 2016 Apr 28;374(17):1609-20
pubmed: 27040324
Circ Cardiovasc Interv. 2015 Oct;8(10):
pubmed: 26453687
Circulation. 2015 Nov 17;132(20):1920-30
pubmed: 26572668
EuroIntervention. 2015 Jul;11(3):343-50
pubmed: 25405801
JACC Cardiovasc Imaging. 2017 Oct;10(10 Pt A):1139-1147
pubmed: 28412434
Circ Cardiovasc Interv. 2015 Jun;8(6):e002408
pubmed: 26033967
Circ Cardiovasc Interv. 2016 May;9(5):e003635
pubmed: 27169577
Circulation. 2016 Jul 12;134(2):130-40
pubmed: 27400898
JACC Cardiovasc Interv. 2013 May;6(5):462-8
pubmed: 23702010
J Am Coll Cardiol. 2012 Jun 19;59(25):2317-26
pubmed: 22503058
Pacing Clin Electrophysiol. 2010 Nov;33(11):1364-72
pubmed: 20723083
Clin Res Cardiol. 2015 Nov;104(11):964-74
pubmed: 25967154
Clin Geriatr Med. 2012 Nov;28(4):703-15
pubmed: 23101579
JACC Cardiovasc Interv. 2016 Apr 25;9(8):805-813
pubmed: 27017367
Eur Heart J. 2014 Jun 21;35(24):1599-607
pubmed: 24179072
JACC Cardiovasc Interv. 2016 Feb 8;9(3):244-254
pubmed: 26847116
Eur Heart J. 2017 Feb 14;38(7):500-507
pubmed: 27252451
Ann Cardiothorac Surg. 2013 Jan;2(1):10-23
pubmed: 23977554
Circulation. 2009 Aug 4;120(5):e29-30
pubmed: 19652115
J Am Coll Cardiol. 2014 Jul 15;64(2):129-40
pubmed: 25011716
JAMA Cardiol. 2016 Apr 1;1(1):46-52
pubmed: 27437653